Profile of p53 expression in bladder and oral tumours: effects of in vitromanipulations of p53 on the behaviour of established human tumour cell lines

Citation
Ame. Nouri et al., Profile of p53 expression in bladder and oral tumours: effects of in vitromanipulations of p53 on the behaviour of established human tumour cell lines, EUR J CANC, 36(14), 2000, pp. 1853-1862
Citations number
31
Categorie Soggetti
Oncology,"Onconogenesis & Cancer Research
Journal title
EUROPEAN JOURNAL OF CANCER
ISSN journal
09598049 → ACNP
Volume
36
Issue
14
Year of publication
2000
Pages
1853 - 1862
Database
ISI
SICI code
0959-8049(200009)36:14<1853:POPEIB>2.0.ZU;2-S
Abstract
In this investigation the profile of p53 and epidermal growth factor recept or (EGFR) expression in tumour tissue biopsies of transitional cell carcino ma of bladder (TCC) and of oral-pharyngeal carcinoma (OP) were compared usi ng an immunocytochemical staining method. In addition, various techniques i ncluding sodium dodecyl sulphate-polyacrylamide gel elecrophoresis (SDS-PAG E), colorimetric assay and gene transfection were used to investigate the i nfluence of p53 on the behaviour of human tumour cell lines in vitro. The r esults showed that: (a) p53 was detectable in more than 45% of cases in bot h tumour types, although the profile and intensity of expression differed. (b) Concomitant strong expression of EGFR and p53 for TCC and OP was 21% an d 38% (P >0.05%), respectively. (c) Treatment of tumour cells by either gam ma radiation or by cisplatin resulted in the induction of p53 independent o f the origin of the tumour. (d) Susceptibility of two cell lines, one with and one without constitutive expression of p53 showed that the expressing c ells were more sensitive to gamma radiation (the percentage inhibition at 2 50 cGy was 57% versus -15%, P< 0.01), and also cisplatin (the percentage in hibition at 1 mu g/ml was 71.0+/-6.0 versus 2.6+/-7.0, P< 0.001). (e) Trans fection of wild-type TP53 gene into a bladder tumour cell line resulted in a rapid cell apoptosis (by as much as 90%) whereas cells receiving mutated TP53 survived. A similar frequency of TP53 mutation in TCCs and OPs was obs erved. In addition. the pattern of p53 expression within the squamous type of TCC was similar to that in OPs. If the data from the in vitro studies co uld be translated into an in vivo setting, one could envisage a situation w here the introduction of wild-type TP53 gene by gene transfection into tumo ur cells (independent of their TP53 gene mutational status), would prove to be beneficial. If the cellular TP53 gene is mutated, then an introduction of the normal TP53 gene would induce cells to undergo apoptosis. Alternativ ely, if TP53 is wild-type, then the increased levels of p53 expression woul d enable the cells to become more susceptible to DNA damaging treatments su ch as cisplatin or gamma radiation. (C) 2000 Elsevier Science Ltd. All righ ts reserved.